北陆药业(300016.SZ)：拟定增募资不超过3亿元

Core Viewpoint - Beilu Pharmaceutical (300016.SZ) plans to raise a total of no more than 300 million yuan through a simplified procedure for issuing shares to specific targets, which does not exceed 20% of the company's net assets at the end of the last fiscal year [1] Fundraising Details - The total amount of funds raised will not exceed 300 million yuan, including the principal amount [1] - The net proceeds from the fundraising, after deducting related issuance costs, will be fully invested in the construction of the Luzhibao chemical drug production workshop and intelligent comprehensive warehouse project, as well as the technical transformation project for a new 100-ton iodinated methyl propyl and 50-ton iodinated butanol raw material production line, and to supplement working capital [1]